OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19
Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1044-1045
Open Access | Times Cited: 12
Fatema Tuz Zahra, Lorenza Bellusci, Gabrielle Grubbs, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 7, pp. 1044-1045
Open Access | Times Cited: 12
Showing 12 citing articles:
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children
Qin Xu, Pedro Milanez‐Almeida, Andrew J. Martins, et al.
Nature Immunology (2022) Vol. 24, Iss. 1, pp. 186-199
Open Access | Times Cited: 63
Qin Xu, Pedro Milanez‐Almeida, Andrew J. Martins, et al.
Nature Immunology (2022) Vol. 24, Iss. 1, pp. 186-199
Open Access | Times Cited: 63
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 34
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 34
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 8
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 8
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 31
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 31
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 2
High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile Infection
Sophie A. Ragan, Caitlin Doyle, Néha Datta, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 26-26
Open Access
Sophie A. Ragan, Caitlin Doyle, Néha Datta, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 26-26
Open Access
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study
Sean Liu, Mila Mirceta, Grace Lin, et al.
Antimicrobial Agents and Chemotherapy (2023)
Open Access | Times Cited: 1
Sean Liu, Mila Mirceta, Grace Lin, et al.
Antimicrobial Agents and Chemotherapy (2023)
Open Access | Times Cited: 1
Robust, persistent adaptive immune responses to SARS-CoV-2 in the oropharyngeal lymphoid tissue of children
Kalpana Manthiram, Qin Xu, Pedro Milanez‐Almeida, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Kalpana Manthiram, Qin Xu, Pedro Milanez‐Almeida, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements
Bruno Deltreggia Benites, Carolina Costa-Lima, Fernanda Batista Rosa Pinto, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 6, pp. 103513-103513
Open Access | Times Cited: 2
Bruno Deltreggia Benites, Carolina Costa-Lima, Fernanda Batista Rosa Pinto, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 6, pp. 103513-103513
Open Access | Times Cited: 2
Intravenous immunoglobulin and convalescent plasma treatment in the COVID-19 patient
Maria Giovanna Danieli, Alberto Paladini, Eleonora Antonelli
Elsevier eBooks (2023), pp. 673-684
Closed Access
Maria Giovanna Danieli, Alberto Paladini, Eleonora Antonelli
Elsevier eBooks (2023), pp. 673-684
Closed Access
Importancia de la diferenciación de la respuesta inmune humoral entre individuos convalecientes, vacunados, y casos incidentes de COVID-19
Luisa F. Duarte, Yaneisi Vásquez, Benjamín Diethelm‐Varela, et al.
Revista del Instituto de Salud Pública de Chile (2023) Vol. 7, Iss. 1
Open Access
Luisa F. Duarte, Yaneisi Vásquez, Benjamín Diethelm‐Varela, et al.
Revista del Instituto de Salud Pública de Chile (2023) Vol. 7, Iss. 1
Open Access
